We are live on
!
Find out more
OCM
Opti Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
0%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
0%
3 Year Est. Return
-0.01%
5 Year Est. Return
+0.33%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
-$601M
(-27%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-84.04%
Top 10 Holdings %
Top 10 Hldgs %
46.31%
Holding
54
New
1
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Integer Holdings
ITGR
|
+$3.77M |
| 2 |
Gossamer Bio
GOSS
|
+$268K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Karyopharm Therapeutics
KPTI
|
+$84.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.76% |
| 2 | Healthcare | 0.24% |
Similar funds
MRG
MB
EPW
TWM
MA
HCMG
LFS
TIM
Opti Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Opti Capital Management held 54 positions worth $1.63B, down 27% from $2.23B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Opti Capital Management withdrew a net $1.37B in Q1 2025, closing 1 position. Its most notable exit was Karyopharm Therapeutics, an estimated $84.5K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, down from 100% a quarter earlier, followed by Healthcare.
Against the trend, Opti Capital Management opened a new position in Integer Holdings worth $3.4M.
- Opti Capital Management's largest Q1 2025 buy was Integer Holdings: 28,832 shares worth $3.4M.
- Opti Capital Management added most to Gossamer Bio in Q1 2025, an estimated $268K increase.
- Opti Capital Management fully exited Karyopharm Therapeutics in Q1 2025, selling an estimated $84.5K.
- Opti Capital Management's ten largest holdings make up 46% of its $1.63B portfolio in Q1 2025.
- Opti Capital Management opened 1 new position and closed 1 in Q1 2025.
- Opti Capital Management's portfolio value fell 27% quarter-over-quarter to $1.63B.
Based on Opti Capital Management's 13F filing for Q1 2025, filed 15 May 2025.